Dyspareunia
Conditions
Interventions
A prospective, randomized, double-blind study will be conducted with 40 patients presenting complaints of chronic pelvic pain (CPP), who will be treated at the Pelvic Pain and Endometriosis Unit of th
Sponsors
Universidade Federal de São Paulo
Universidade Federal de São Paulo
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women; pelvic pain or genito-pelvic/penetration pain (GPPPD) for more than six months will be included; with a trigger point in the pelvic floor; aged between 18 and 45 years; sexually active with penetration (at least once a month); experiencing pelvic pain and pain during intercourse, with a score equal to or greater than four on the Numerical Rating Scale (NRS)
Exclusion criteria
Exclusion criteria: Women with obesity (body mass index [BMI] >30); current urinary tract infection; leukorrhea (such as candidiasis or bacterial vaginosis); acute vulvar or vaginal lesions (e.g., Human papillomavirus, herpes, fissures); pregnant women; women with suspected pelvic cancer; pelvic organ prolapse beyond the hymenal ring during Valsalva maneuver; hypertrophic scars; vulvodynia; vaginismus; moderate to heavy menstrual leakage or increased and irregular uterine bleeding. During the study, patients who did not attend at least 70% of the sessions were excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: It is expected that there will be a decrease in the intensity of genito-pelvic/penetration pain complaints after photobiomodulation treatment (p < 0.001). Regarding the female sexual function index (FSFI) questionnaire, a decrease in the pain domain score is also expected following photobiomodulation application (p < 0.001) ;Outcome found: Regarding the intensity of genito-pelvic/penetration pain, there was a reduction in complaints after the application of photobiomodulation (p < 0.001). In the female sexual function index (FSFI) questionnaire, we observed a significant decrease in the pain domain after photobiomodulation (PBM) application (p < 0.001). There was also a significant improvement in desire (p = 0.010), arousal (p = 0.033), and satisfaction (p = 0.018). However, no statistically significant difference was observed in vaginal lubrication and orgasm | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes were expected | — |
Countries
Brazil
Contacts
Public ContactBruna Chamma
Universidade Federal de São Paulo
Outcome results
None listed